May 11, 2020 / 7:55 AM / 15 days ago

BRIEF-Pharma Mar And Megapharm Sign Licensing Agreement For Lurbinectedin In Israel

May 11 (Reuters) - Pharma Mar SA:

* SAYS PHARMAMAR AND MEGAPHARM SIGN A LICENSING AGREEMENT FOR LURBINECTEDIN IN ISRAEL

* SAYS WILL RETAIN EXCLUSIVE PRODUCTION RIGHTS AND WILL SELL THE PRODUCT TO MEGAPHARM FOR COMMERCIAL USE

* LURBINECTEDIN'S NDA IS BEING EVALUATED BY FDA SEEKING ACCELERATED APPROVAL IN U.S. FOR TREATMENT OF PATIENTS WITH SMALL CELL LUNG CANCER Source text: bit.ly/35QjZcc Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below